| Literature DB >> 27780885 |
Daland R Juberg1, Thomas B Knudsen2, Miriam Sander3, Nancy B Beck4, Elaine M Faustman5, Donna L Mendrick6, John R Fowle7, Thomas Hartung8, Raymond R Tice9, Emmanuel Lemazurier10, Richard A Becker4, Suzanne Compton Fitzpatrick11, George P Daston12, Alison Harrill13, Ronald N Hines2, Douglas A Keller14, John C Lipscomb15, David Watson16, Tina Bahadori17, Kevin M Crofton2.
Abstract
Future Tox III, a Society of Toxicology Contemporary Concepts in Toxicology workshop, was held in November 2015. Building upon Future Tox I and II, Future Tox III was focused on developing the high throughput risk assessment paradigm and taking the science of in vitro data and in silico models forward to explore the question-what progress is being made to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. This article reports on the outcome of the workshop including 2 examples of where advancements in predictive toxicology approaches are being applied within Federal agencies, where opportunities remain within the exposome and AOP domains, and how collectively the toxicology community across multiple sectors can continue to bridge the translation from historical approaches to Tox21 implementation relative to risk assessment and regulatory decision-making.Entities:
Keywords: in vitro and alternatives; predictive toxicology; regulatory/policy; risk assessment; testing alternatives.
Mesh:
Year: 2016 PMID: 27780885 PMCID: PMC6080854 DOI: 10.1093/toxsci/kfw194
Source DB: PubMed Journal: Toxicol Sci ISSN: 1096-0929 Impact factor: 4.849